tailieunhanh - Heparan sulfate mediates trastuzumab effect in breast cancer cells

Trastuzumab is an antibody widely used in the treatment of breast cancer cases that test positive for the human epidermal growth factor receptor 2 (HER2). Many patients, however, become resistant to this antibody, whose resistance has become a major focus in breast cancer research. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN